Qu Deng

Qu Deng

University of Pennsylvania

H-index: 8

North America-United States

About Qu Deng

Qu Deng, With an exceptional h-index of 8 and a recent h-index of 8 (since 2020), a distinguished researcher at University of Pennsylvania, specializes in the field of Targeted Therapy, Cancer Biomarker, Molecular Carcinogenesis, Cancer Epigenetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance

Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1

Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19

Targeting transcriptional addiction in anti-androgen refractory castration-resistant prostate cancer

Qu Deng Information

University

Position

___

Citations(all)

650

Citations(since 2020)

528

Cited By

338

hIndex(all)

8

hIndex(since 2020)

8

i10Index(all)

8

i10Index(since 2020)

8

Email

University Profile Page

Google Scholar

Qu Deng Skills & Research Interests

Targeted Therapy

Cancer Biomarker

Molecular Carcinogenesis

Cancer Epigenetics

Top articles of Qu Deng

Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance

Nature Communications

2023/8/29

Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1

Cell reports

2022/6/14

Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19

IScience

2021/3/19

Targeting transcriptional addiction in anti-androgen refractory castration-resistant prostate cancer

Cancer Research

2020/8/15

See List of Professors in Qu Deng University(University of Pennsylvania)